|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 470.89 USD | -1.02% |
|
-4.04% | -3.33% |
EPS & Dividend: United Therapeutics Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 11.54 | 10.06 | 15 | 19.81 | 24.64 | 27.09 | 28.6 | 30.77 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 151.79 | 216.08 | 278.09 | 219.89 | 352.84 | 475.73 | 475.73 | 475.73 |
| Nbr of stocks (in thousands) | 44,441 | 45,037 | 45,577 | 46,994 | 44,645 | 43,057 | 43,057 | - |
| Announcement Date | 24/02/21 | 24/02/22 | 22/02/23 | 21/02/24 | 26/02/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: United Therapeutics Corporation
| 25/02/2026 | Q4 2025 Earnings Release (Projected) |
| 06/05/2026 | Q1 2026 Earnings Release (Projected) |
| 05/08/2026 | Q2 2026 Earnings Release (Projected) |
| 04/11/2026 | Q3 2026 Earnings Release (Projected) |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | 17.56x | 2.54x | 5.43x | |
| 0.55% | 0.62% | 46.89x | 35.8x | 15.52x | |
| 2.36% | 2.43% | 21.23x | 6.72x | 5.89x | |
| 2.95% | 3.07% | 75.19x | 702.52x | 7.36x | |
| 2.87% | 2.92% | 20.01x | 7.12x | 5x | |
| 1.67% | 1.76% | 29.15x | 6.55x | 5.47x | |
| 2.81% | 2.93% | 20.36x | 6.39x | 5.38x | |
| 2.91% | 2.96% | 14.22x | 5.11x | 4.66x | |
| 3.08% | 3.01% | 16.39x | 8.91x | 5.8x | |
| 2.91% | 3.05% | 25.73x | 19.58x | 6.1x | |
| Average | 2.21% | 2.27% | 28.67x | 80.12x | 6.66x | |
| Weighted average by Cap. | 2.08% | 2.15% | 33.87x | 91.84x | 8.39x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition